Our productive engagement with the European Medicines Agency (EMA) highlighted by confirmation of eligibility to submit for a conditional ...

Please provide your email address to receive an email when new articles are posted on . The recommendation was extended to Vyjuvek, a topical that delivers gene copies that address the root cause of ...

After years of delay, millions of malaria vaccines are being supplied to children in Africa. Tens of thousands died waiting. By Stephanie Nolen The drug, used to treat diabetes, has become popular as ...

AMSTERDAM (Reuters) - The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social media ...

Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced that its lead product candidate, NRTX-1001, ...

Please provide your email address to receive an email when new articles are posted on . The committee recommended the launch of Ituxredi as a biosimilar of MabThera. Ituxredi will be indicated for ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the Most Undervalued Long Term Stocks to Buy Right Now. On October 17, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced that the European ...

EMA's CHMP issued a positive opinion for Novartis' Kisqali for high-risk early breast cancer. Kisqali showed a 25.1% reduced risk of cancer recurrence in Phase 3 NATALEE trial. Get access to the ...

The European medicines regulator said on Tuesday some COVID-19-related documents and data that were accessed in a cyber ...

Endeavor BioMedicines ("Endeavor"), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational benefits to patients with life-threatening diseases, ...